Tissue plasminogen activator plasma levels as a potential diagnostic aid in acute pulmonary embolism

Archives of Pathology and Laboratory Medicine

Volumn 127, Issue 3, 2003, Pages 310-315

  Flores, Julio ^a   García Avello, Angel ^b   Flores, Victor M ^c   Navarro, José L ^d   Canseco, Felipe ^a   Pérez Rodríguez, Esteban ^b  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPLASMIN; D DIMER; PLASMIN; TISSUE PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR DERIVATIVE; TISSUE PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; HUMAN; LUNG ANGIOGRAPHY; LUNG EMBOLISM; LUNG SCINTISCANNING; LUNG VENTILATION PERFUSION RATIO; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; UNIVERSITY HOSPITAL;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; ANTIPLASMIN; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MIDDLE AGED; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PULMONARY EMBOLISM; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 0037344945     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Moser K. Venous embolism. Am Rev Respir Dis. 1990;141:235-249.
2. Palla A, Pazzagli M, Donnamaria V, et al. The role of suspicion in the diagnosis of pulmonary embolism. Chest. 1995;107:21S-24S.
3. Stein PD, Terrin ML, Hales CA, et al. Clinical, laboratory, roentgenographic and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease. Chest. 1991;100:598-603.
4. Stein PD, Goldhaber SZ, Henry JW, et al. Alveolar-arterial oxygen gradient in the assessment of acute pulmonary embolism. Chest. 1995;107:139-143.
5. The PIOPED investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). JAMA. 1990;263:2753-2759.
6. The PISA-PED investigators. Invasive and noninvasive diagnosis of pulmonary embolism: preliminary results of the Prospective Investigative Study of Acute Pulmonary Embolism Diagnosis (PISA-PED). Chest. 1995;107:33S-38S.
7. Stein PD, Athanasoulis C, Alavi A. Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation. 1992;85:462-468.
8. Gaffney PJ, Brasher M. Subunit structure of the plasmin induced degradation products of crosslinked fibrin. Biochim Biophys Acta. 1973;295:308-313.
9. Bounameaux H, Cirafici P, De Moerloose P, et al. Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism. Lancet. 1991;337:196-200.
10. Flores J, Lancha C, Pérez Rodríguez E, et al. Efficacy of D-dimer and total fibrin degradation products evaluation in suspected pulmonary embolism. Respiration. 1995;62:258-262.
11. Goldhaber SZ, Simons GR, Elliott CG, et al. Quantitative plasma D-dimer levels among patients undergoing pulmonary angiography for suspected pulmonary embolism. JAMA. 1993;270:2819-2822.
12. Perrier A, Desmarais S, Goenhring C, et al. D-dimer testing for suspected pulmonary embolism in outpatients. Am J Respir Crit Care Med. 1997;156:492-496.
13. Ginsberg JS, Brill-Edwards P, Demers C, et al. D-dimer in patients with clinically suspected pulmonary embolism. Chest. 1993;104:1679-1684.
14. Garcfa Frade LJ, Sureda A. Productos de degradación del fibrinógeno/fibrina: métodos de determinación y utilidad clínica. Rev Iberoam Tromb Hemost. 1991;4:89-98.
15. Lijnen HG, Collen D. Mechanisms of physiological fibrinolysis. Baillieres Clin Haematol. 1994;7:277-289.
16. Booth NA, Bennett B. Fibrinolysis and thrombosis. Baillieres Clin Haematol. 1994;7:559-571.
17. Stein PD, Henry W, Gottschalk A. The addition of clinical assessment to stratification according to prior cardiopulmonary disease further optimizes the interpretation of ventilation/perfusion lung scans in pulmonary embolism. Chest. 1993;104:1472-1476.
18. Stein PD, Hull RD, Saltzman HA, et al. Strategy for diagnosis of patients with suspected acute pulmonary embolism. Chest. 1993;103:1553-1559.
19. Hyers TM. Diagnosis of pulmonary embolism. Thorax. 1995;50:930-932.
20. Ránby M, Bersdorf N, Nilsson T, et al. Age dependence of tissue plasminogen activator concentrations in plasma as studied by an improved enzyme linked immunosorbent assay. Clin Chem. 1986;32:160-165.
21. Declerck P, Alessi MC, Verstreken M, et al. Measurement of plasminogen activator inhibitor 1 in biological fluids with a murine monoclonal antibody based enzyme linked immunosorbent assay. Blood. 1988;71:220-225.
22. Collen D, de Cock F, Plow E. Quantitation of neoantigens specific for thrombin-antithrombin III and plasmin-alfa2-antiplasmin complexes, Prog Fibrinol. 1981;5:157-163.
23. De Moerloose P, Desmarais S, Bounameaux H, et al. Contribution of a new, rapid, individual and quantitative automated D-dimer ELISA to exclude pulmonary embolism. Thromb Haemost. 1996;1:11-13.
24. Jenicek M, Clèroux R. Epidemiología: Principios: Técnicas; Aplicaciones. Barcelona, Spain: Salvat; 1987.
25. Speiser W, Mallek R, Koppensteinert R, et al. D-dimer and TAT measurement in patients with deep venous thrombosis: utility in diagnosis and judgement of anticoagulant treatment effectiveness. Thromb Haemostas. 1990;64:198-201.
26. Latham B, Hufoy E, Barret O, et al. Deficient tissue plasminogen activator release and normal tissue plasminogen activator inhibitor in a patient with recurrent deep vein thrombosis. Am J Med. 1990;88:199-200.
27. ACCP Consensus Committee on Pulmonary Embolism. Opinions regarding the diagnosis and management of venous thromboembolic disease. Chest. 1998;113:499-504.
28. Van Beek EJR, van den Ende B, Berckmans RJ, et al. A comparative analysis of D-dimer assays in patients with clinically suspected pulmonary embolism. Thromb Haemost. 1993;70:408-413.
29. Sijens EP, van Ingen HE, van Beek EJR, Berghout A, Oudkerk M. Rapid ELISA assay for plasma D-dimer in the diagnosis of segmental and subsegmental pulmonary embolism. Thomb Haemost. 2000;84:156-159.
30. Minnema MC, ten Cate H, van BeeK EJR, van de Ende A, Hack CE. Effects of heparin therapy on fibrinolysis in patients with pulmonary embolism. Thromb Haemost. 1997;77:1164-1167.
31. Estivals M, Pelzer H, Sie P, Boccalon H, Boneu B. Prothrombin fragment 1 + 2, thrombi-antithrombin III complex and D-dimers in acute deep venous thrombosis: effect of heparin treatment. Br J Haematol. 1991;78:421-424.
32. Boneu B, Bes G, Pelzer H, Sie P, Boccalon H. D-dimers, thrombin-antithrombin III complex and prothrombin fragment 1 + 2: diagnosis value in clinically suspected deep vein thrombosis. Thromb Haemost. 1991;65:28-32.
33. Heit JA, Minor TA, Andrews JC, Larson DR, Li H, Nichols WL. Determinants of plasma fibrin D-dimer sensitivity for acute pulmonary embolism as defined by pulmonary angiography. Arch Pathol Lab Med. 1999;123:235-240.
34. Deitcher S, Lucore C, Eisenber P. Impaired resolution of massive pulmonary embolism associated with inhibited fibrinolytic response. Am J Med. 1994;96:483-484.